HEAVILY OVERSUBSCRIBED ISSUING

IDEON Science park: The NGM listed blood analysis company LifeAssays® capital stock issuing, during the period March 6-31 2006, was three-times oversubscribed.

“I am very happy and feel a great respect for the confidence that our shareholders have shown the company. It has been a fantastic journey from the invention that I made in the early nineties, which is now being established as a product and a Point-Of-Care aid for, among other things, the assessment of cardiovascular risk. With a treasury of 11 million SEK and the attention from distributors and leading companies, I am convinced that we will be able to deliver more positive news during 2006,” says the CEO Dr. Dario Kriz.

Company board of LifeAssays

IDEON SCIENCE PARK • SE-223 70 LUND • SWEDEN

TEL: 046 – 286 54 00 • FAX: 046 – 286 54 19

LifeAssays®’ business idea is the development, manufacture and sales of Point-Of-Care equipment/consumables which are based on the Magneto ImmunoAssay technology platform. The technology is user friendly, accurate and fast and has attracted international attention.

For more information contact LifeAssays® AB, Dr. Dario Kriz

Phone +46 (46) 2865400

Email: info@lifeassays.com

The material above may freely be used for publication in Swedish and International media.